Welcome Guest

Abstract
Add to Favorites
  • Volume 5
  •  Issue 3
  • Publication Date: December 2006


Significance of B7-H1 Overexpression in Kidney Cancer


R. Houston Thompson, Eugene D. Kwon

B7-H1 is a cell surface glycoprotein belonging to the B7 family of co-stimulatory molecules. Constitutive protein expression is restricted to a fraction of macrophage-lineage cells, although B7-H1 can be induced on activated T lymphocytes. In addition, some human tumor cells can acquire the ability to aberrantly express B7-H1. In vitro studies demonstrate that B7-H1, expressed by tumor cells or activated lymphocytes, impairs T-cell function and survival and enhances apoptosis of activated tumor-specific T cells. Consistent with this, in vivo monoclonal antibody blockade of B7-H1 has been shown to potentiate antitumor responses in several murine cancer models. Thus, tumor-associated B7-H1 has recently garnered much attention as a potential inhibitor of host antitumor immunity. We describe herein the published investigations looking at the role of B7-H1 in renal cell carcinoma (RCC). Clinical observations demonstrate that B7-H1 is aberrantly expressed in primary and metastatic RCC. The group from Mayo Clinic recently performed immunohistochemistry on fresh-frozen and paraffin-embedded nephrectomy specimens. All patients had clear-cell RCC, and pathologic evaluation was performed by a single urologic pathologist. Their results demonstrated that B7-H1, expressed by tumor cells or lymphocytes, is associated with aggressive pathologic features, including TNM stage, nuclear grade, tumor size, and coagulative necrosis. With a median clinical follow-up of 11 years, patients with tumor B7-H1 were at significant risk of disease progression, cancer-specific death, and overall mortality even after multivariate analyses. Five-year cancer-specific survival rates were 42% and 83% for patients with and without tumor B7-H1, respectively. The basis for these associations could relate to the recognized ability of B7-H1 to inhibit antitumor T-cell-mediated immunity. Based on the current literature, B7-H1 is an independent predictor of prognosis in RCC and represents a promising target for immune manipulation in this refractory tumor.

Key words: Antigens, Immunotherapy, T lymphocytes, Tumor biomarkers



  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  16. pintarbersamamedan.org
  17. https://pintarbersamamanado.org
  18. https://pintarbersamasorong.org/dana
  19. DATA HK
  20. HK LOTTO
  21. PENGELUARAN HK
  22. DATA HK
  23. TOGEL HK
  24. PENGELUARAN SGP
  25. TOGEL SDY
  26. TOGEL HONGKONG
  27. PENGELUARAN SGP
  1. KELUARAN SGP
  2. TOGEL